PFM Health Sciences’s Abbott ABT Stock Holding History

PFM Health Sciences’s Portfolio ABT Stock Details ABT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$14.4M	Buy	+140,432	New	+$15.9M	1.31%	23
2020 Q1	–	Sell	-322,713	Closed	-$28M	–	62
2019 Q4	$28M	Buy	+322,713	New	+$27M	1.34%	29
2019 Q1	–	Sell	-1,144,699	Closed	-$82.8M	–	91
2018 Q4	$82.8M	Sell	1,144,699 -82,361	-7%	-$5.79M	2.2%	11
2018 Q3	$90M	Sell	1,227,060 -110,228	-8%	-$7.24M	1.32%	24
2018 Q2	$81.6M	Sell	1,337,288 -419,508	-24%	-$25.4M	1.28%	22
2018 Q1	$105M	Buy	1,756,796 +24,254	+1%	+$1.46M	2.14%	10
2017 Q4	$98.9M	Sell	1,732,542 -68,426	-4%	-$3.79M	2.35%	6
2017 Q3	$96.1M	Buy	1,800,968 +698,187	+63%	+$35M	1.89%	13
2017 Q2	$53.6M	Buy	+1,102,781	New	+$49.9M	1.44%	27

Other funds holding ABT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

PFM Health Sciences's ABT Position: Q1 2026 in Review

PFM Health Sciences opened a new position in Abbott (ABT) in Q1 2026: 140,432 shares worth $14.4M. The stake represents 1.31% of the portfolio and ranks #23 among its holdings. This is a return to the name: PFM Health Sciences previously reported a position in ABT as recently as Q4 2019.

PFM Health Sciences first reported a position in ABT in Q2 2017 and has held it in 9 quarters since. The position peaked at $105M in Q1 2018. 3,086 funds tracked by Wall St. Rank hold ABT as of Q1 2026.

PFM Health Sciences held 140,432 shares of Abbott worth $14.4M as of Q1 2026.
Abbott was a new PFM Health Sciences position in Q1 2026.
Abbott made up 1.31% of PFM Health Sciences's portfolio in Q1 2026, its #23 holding.
PFM Health Sciences first reported a position in Abbott in Q2 2017 and has held it in 9 quarters since.
PFM Health Sciences's Abbott position peaked at $105M in Q1 2018.
3,086 funds tracked by Wall St. Rank held Abbott as of Q1 2026.

Based on PFM Health Sciences's 13F filing for Q1 2026, filed 15 May 2026.